SCHEMBL7140079

SCHEMBL7140079

CO/C=C(/C(=O)O)c1ccccc1/C=C/C=C/c1ccc(Br)s1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 2/20 0.34
RAB9A P51151 6/20 0.34
MAPT P10636 5/20 0.34
AR P10275 1/20 0.33
MAOB P27338 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPC1 O15118 5/20 0.32
KDM4E B2RXH2 2/20 0.32
ABCB1 P08183 1/20 0.32
LY96 Q9Y6Y9 1/20 0.32
LMNA P02545 4/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
GAA P10253 1/20 0.31
MEN1 O00255 2/20 0.31
HTT P42858 2/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7140082 1.00 KMT2A (0.34) KMT2AALDH1A1RAB9AMAPTAR
SCHEMBL7142510 0.87 ALDH1A1 (0.40) KMT2AALDH1A1RAB9AMAPTAR
SCHEMBL7142506 0.87 ALDH1A1 (0.40) KMT2AALDH1A1RAB9AMAPTAR
SCHEMBL7140258 0.83 LY96 (0.47) KMT2AALDH1A1RAB9AMAPTAR
SCHEMBL7140256 0.83 LY96 (0.47) KMT2AALDH1A1RAB9AMAPTAR
SCHEMBL7139096 0.80 MAOB (0.42) KMT2AALDH1A1ARMAOBCYP1A2
SCHEMBL7139094 0.80 MAOB (0.42) KMT2AALDH1A1ARMAOBCYP1A2
SCHEMBL7141886 0.80 TUBB4A (0.40) ARMAOB
SCHEMBL7141881 0.80 TUBB4A (0.40) ARMAOB
SCHEMBL7144515 0.77 KDM1A (0.44) KMT2AALDH1A1RAB9AMAPTAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996439-B1 BETA-ALKOXYACRYLATES AGAINST MALARIA HOFFMANN LA ROCHE (CH) 2003-01-08 EP disclosed
US-6084120-A ACTIVE AGAINST CHLOROQUINE-SENSITIVE PATIENTS AND AGAINST CHLOROQUINE-RESISTANT MALARIA PATHOGENS; PROPHYLAXIS AND TREATMENT; E.G., A 3 METHOXY-2-(2-(4-PHENYLBUTA-1,3-DIEN-1-YL)PHENYL)ACRYLIC ACID HOFFMANN-LA ROCHE INC. (US) 2000-07-04 US disclosed